Pharmaceutical Industry Current Affairs, GK & News
PLI Scheme: Critical Bulk Drugs approved
The Ministry of Chemical and Fertilizers recently approved sixteen applicants under Production Linked Incentive scheme. The approvals will promote domestic manufacturing of drug intermediates and Active Pharmaceutical Ingredients in the country. What is the plan? The approved applicants will set up pharmaceutical manufacturing plants in the country. They will invest around Rs 348 crores in ..
Month: Current Affairs - April, 2021
Category: Government Schemes Current Affairs
Topics: Active Pharmaceutical Ingredients (API) • COVID-19 • India China • Indian Imports • Pharmaceutical Industry • Pharmaceutical industry in China • Pharmaceutical industry in India • Production Linked Incentive (PLI)
GoI to launch Rs 25,000 crore plan to cut Chinese Imports
The Government of India is to launch a production linked incentive scheme in order to reduce dependence on Chinese import of chemicals. The scheme will have an outlay of Rs 25,000 crores and is to be implemented over the next five years. Highlights The department of chemicals over a series of recent meeting, has identified ..
Month: Current Affairs - September, 2020
Category: Government Schemes Current Affairs
Topics: active pharmaceutical ingredient (API) • bulk drug park • India China • Pharmaceutical Industry • production linked incentive scheme
Andhra Pradesh signs MoU with CSIR-IICT on Bulk Drug Park
The Andhra Pradesh Industrial Infrastructure Corporation Ltd (APIIC) has entered into a Memorandum of Understanding (MoU) with Council of Scientific and Industrial Research – Indian Institute of Chemical Technology (CSIR-IICT) as a step forward in the direction of setting up a Bulk Drug Park (BDP) under a scheme by the Ministry of Chemicals and Fertilisers, ..
Month: Current Affairs - September, 2020
Category: Government Schemes Current Affairs • States Current Affairs
Topics: Andhra Pradesh • bulk drug park • Memorandum of understanding • Ministry of Chemicals and Fertilizers • Pharmaceutical Industry • self reliant india
‘Active Pharmaceutical Ingredients’ Report Published by TIFAC
Technology Information Forecasting and Assessment Council, an autonomous organization working under the Department of Science and Technology, has released the report on the API development in India. The report titled ‘Active Pharmaceutical Ingredients – Status, Issues, Technology Readiness’ has focused on the need to beef up the indigenous production of the APIs in the country. ..
Month: Current Affairs - July, 2020
Category: Reports & Indexes Current Affairs
Topics: active pharmaceutical ingredient (API) • Pharmaceutical Industry • TIFAC
Three Bulk Drug Parks and Four Medical Devices Park to be established in India
On July 13, 2020, the Union Ministry of Chemicals and Fertilizers finalised guidelines to select three bulk drug parks and four medical devices parks. Highlights The parks are to be set up at Bhatindia in the state of Punjab. Bhatindia has been selected as it has good connectivity of water and land availability. The state ..
Month: Current Affairs - July, 2020
Category: Government Schemes Current Affairs • India Nation & States Current Affairs
Topics: active pharmaceutical ingredient (API) • AIIMS • All India Institute of Medical Sciences (AIIMS) • Indian Institute of Science Education and Research (IISER) • Medical Device Parks • NIPER • Pharmaceutical Industry • production linked incentive scheme
Export Restriction on 26 Pharmaceutical Ingredients
In light of the ongoing coronavirus outbreak, the government has imposed restrictions on the export of 26 pharmaceutical ingredients. Active Pharmaceutical Ingredients: Active Pharmaceutical Ingredient or API is the raw material used for drug manufacture. It is the actual component that brings about the intended effect. Some drugs have multiple APIs. A drug is composed ..
Topics: API • Chinese Imports • COVID-19 • Export Restrictions • Pharmaceutical Industry